James Nagarajah on [177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
de
The Lancet Oncology in conversation with
2026-03-30 23:00:00
Fecha de lanzamiento
10:55
Duración
